As of 2025-05-26, the Relative Valuation of Moderna Inc (MRNA) is (102.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.26 USD, the upside of Moderna Inc based on Relative Valuation is -488.5%.
The range of the Relative Valuation is (99.68) - (108.19) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 12.5x | 11.5x |
| Forward P/E multiples | 11.5x - 13.1x | 12.0x |
| Fair Price | (99.68) - (108.19) | (102.02) |
| Upside | -479.6% - -512.0% | -488.5% |
| Date | P/E |
| 2025-05-23 | -3.02 |
| 2025-05-22 | -3.08 |
| 2025-05-21 | -2.97 |
| 2025-05-20 | -3.22 |
| 2025-05-19 | -3.04 |
| 2025-05-16 | -2.86 |
| 2025-05-15 | -2.72 |
| 2025-05-14 | -2.77 |
| 2025-05-13 | -2.94 |
| 2025-05-12 | -2.96 |
| 2025-05-09 | -2.79 |
| 2025-05-08 | -2.81 |
| 2025-05-07 | -2.77 |
| 2025-05-06 | -2.81 |
| 2025-05-05 | -3.21 |
| 2025-05-02 | -3.18 |
| 2025-05-01 | -3.11 |
| 2025-04-30 | -3.29 |
| 2025-04-29 | -3.20 |
| 2025-04-28 | -3.16 |
| 2025-04-25 | -3.13 |
| 2025-04-24 | -3.15 |
| 2025-04-23 | -3.06 |
| 2025-04-22 | -2.96 |
| 2025-04-21 | -2.89 |
| 2025-04-17 | -2.85 |
| 2025-04-16 | -2.90 |
| 2025-04-15 | -3.02 |
| 2025-04-14 | -3.09 |
| 2025-04-11 | -3.02 |
| 2025-04-10 | -2.82 |
| 2025-04-09 | -3.07 |
| 2025-04-08 | -2.84 |
| 2025-04-07 | -2.95 |
| 2025-04-04 | -2.89 |
| 2025-04-03 | -2.96 |
| 2025-04-02 | -3.19 |
| 2025-04-01 | -3.13 |
| 2025-03-31 | -3.27 |
| 2025-03-28 | -3.58 |
| 2025-03-27 | -3.70 |
| 2025-03-26 | -3.63 |
| 2025-03-25 | -3.90 |
| 2025-03-24 | -3.94 |
| 2025-03-21 | -3.76 |
| 2025-03-20 | -3.74 |
| 2025-03-19 | -3.84 |
| 2025-03-18 | -3.89 |
| 2025-03-17 | -4.00 |
| 2025-03-14 | -3.99 |